combination therapy – SASHA: South Australian Sexual Health Awareness

Updated guidelines for PEP (Post-Exposure Prophylaxis) after non-occupational and occupational exposure to HIV 

2 Min Read

U

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), June 2023 ASHM has updated the National Guidelines for Post-Exposure Prophylaxis (PEP) after non-occupational and occupational exposure to HIV . These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure...

Read on Read later

FDA Approves Cabenuva, the First Complete Long-Acting Injectable HIV Treatment

By J Pope

In HIV

1 Min Read

F

Poz.com, January 21, 2021 On January 21, the Food and Drug Administration (FDA) in the USA approved the first complete injectable HIV treatment regimen that does not require daily pills. Cabenuva, from ViiV Healthcare, is administered only once a month. It is approved for people with an undetectable viral load on their current therapy who wish to switch to a long-acting regimen. Cabenuva consists...

Read on Read later

Case report: HIV-associated neurocognitive disorder & myelopathy in patient with preserved CD4, but high viral load

By J Pope

In HIV

1 Min Read

C

HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review. Ayele, B.A., Amogne, W. & Gemechu, L. BMC Infect Dis 20, 574 (2020). This case supports the current understanding regarding the persistent occurrence of HIV-associated neurocognitive disorder and HIV...

Read on Read later

Information about TRUVADA and ATRIPLA delisting

By J Pope

In Gay Lesbian & Bisexual Health, HIV, LGBTIQ+ issues

1 Min Read

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

Read on Read later

HIV vaccine therapy lets five people control virus without drugs

By J Pope

In HIV

1 Min Read

H

New Scientist, 22 February 2017
FIVE people with HIV are currently free of detectable virus – and daily drugs – thanks to a new vaccine-based therapy.
Although it is early days, one participant has been drug-free for seven months.
Read more here

Read on Read later

Anti-booze drug may flush out dormant HIV and could lead to cure

By J Pope

In HIV

1 Min Read

A

New Scientist, 16 November 2015
It could be just what HIV researchers the world over have been waiting for – a non-toxic drug that will drive the virus from its hiding places around the body. What is it? The well-known anti-alcohol drug, Antabuse.
Read more here

Read on Read later

Tagcombination therapy